Past Funding

At the latest research and innovation mixer hosted at Children’s National Hospital’s Research & Innovation Campus, the energy in the room felt more like a startup demo day than a hospital meeting. In tandem with the hospital’s Innovation Acceleration Network (IAN), an initiative designed to connect clinicians, researchers and engineers who might not otherwise collaborate, the mission of the event was to support pediatric innovators and accelerate early-stage technologies that often struggle to find funding or institutional backing.
Through small pilot awards and a pitch competition, funded by the Alliance for Pediatric Device Innovation’s FDA P50 grant, innovators can receive between $20,000 and $50,000 to push their projects forward. Since its inception, more than 300 devices and concepts have moved through the initiative at various stages of development.

MURI BEI BERN, Switzerland, Jan. 8, 2026 — Compremium AG today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its novel solution designed to directly measure central venous pressure (CVP) non-invasively. The device has also joined the FDA’s Total Product Life Cycle Advisory Program (TAP). Volume assessment is critical for hemodynamic management of patients requiring close monitoring across acute conditions such as sepsis, shock, heart failure, venous congestion, and fluid under- or overload. Today’s gold standard relies on central venous pressure measured invasively with catheterization, which carries risks including infection and thrombosis.